Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.
Roberts SC, Jain S, Tremoulet AH, Kim KK, Burns JC; KIDCARE Multicenter Study Group; Anand V, Anderson M, Ang J, Ansusinha E, Arditi M, Ashouri N, Bartlett A, Chatterjee A, DeBiasi R, Dekker C, DeZure C, Didion L, Dominguez S, El Feghaly R, Erdem G, Halasa N, Harahsheh A, Jackson MA, Jaggi P, Jain S, Jone PN, Kaushik N, Kurio G, Lillian A, Lloyd D, Manaloor J, McNelis A, Michalik DE, Newburger J, Newcomer C, Perkins T, Portman M, Romero J, Ronis T, Rowley A, Schneider K, Schuster J, Tejtel SKS, Sharma K, Simonsen K, Szmuszkovicz J, Truong D, Wood J, Yeh S. Roberts SC, et al. Among authors: kaushik n. Contemp Clin Trials. 2019 Apr;79:98-103. doi: 10.1016/j.cct.2019.02.008. Epub 2019 Mar 3. Contemp Clin Trials. 2019. PMID: 30840903 Free article.
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, Jain SS, Michalik DE, Sharma K, Truong DT, Wood JB, Kim KK, Jain S; KIDCARE Multicenter Study Group. Burns JC, et al. Lancet Child Adolesc Health. 2021 Dec;5(12):852-861. doi: 10.1016/S2352-4642(21)00270-4. Epub 2021 Oct 27. Lancet Child Adolesc Health. 2021. PMID: 34715057 Free article. Clinical Trial.
COVID-19 Vaccination-Associated Myocarditis in Adolescents.
Jain SS, Steele JM, Fonseca B, Huang S, Shah S, Maskatia SA, Buddhe S, Misra N, Ramachandran P, Gaur L, Eshtehardi P, Anwar S, Kaushik N, Han F, Chaudhuri NR, Grosse-Wortmann L. Jain SS, et al. Among authors: kaushik n. Pediatrics. 2021 Nov;148(5):e2021053427. doi: 10.1542/peds.2021-053427. Epub 2021 Aug 13. Pediatrics. 2021. PMID: 34389692
Young Child With Seizure.
Watkins K, Gelber J, Kaushik N, Shaahinfar A. Watkins K, et al. Among authors: kaushik n. Ann Emerg Med. 2021 Jun;77(6):597-600. doi: 10.1016/j.annemergmed.2020.10.002. Ann Emerg Med. 2021. PMID: 34030774 No abstract available.
Cardiac arrest and pulmonary hypertension in scurvy: a case report.
Dean T, Kaushik N, Williams S, Zinter M, Kim P. Dean T, et al. Among authors: kaushik n. Pulm Circ. 2019 Jan-Mar;9(1):2045894018812052. doi: 10.1177/2045894018812052. Epub 2018 Oct 23. Pulm Circ. 2019. PMID: 30351242 Free PMC article.
Myocarditis in children after COVID-19 vaccine.
Aljohani OA, Arcilla L, Kaushik N, Cresalia NM, Li B, Edwell AA, Ramirez AM, Anwar S. Aljohani OA, et al. Among authors: kaushik n. Ann Pediatr Cardiol. 2022 May-Jun;15(3):280-283. doi: 10.4103/apc.apc_135_21. Epub 2022 Nov 16. Ann Pediatr Cardiol. 2022. PMID: 36589642 Free PMC article.
424 results